Shares of Gilead Sciences Inc. rose after the company’s antiviral drug remdesivir became the first approved treatment for Covid-19 in the United States.
First U.S. novel coronavirus reinfection case identified in Nevada study (Reuters) – Researchers for the first time have identified someone in the United States who was reinfected with the novel […]
The anti-malaria drug touted by U.S. President Donald Trump as a Covid-19 treatment was ineffective for patients with a mild version of the disease in a study conducted by researchers at the University of Minnesota.
Bay Area-based Genentech launched a new study assessing the company’s rheumatoid arthritis drug Actemra as a potential treatment for COVID-19 with an eye toward increasing diversity and inclusion among patients treated.
